Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Marpai (NASDAQ:MRAI) versus Auna (NYSE:AUNA) Head-To-Head Analysis

Дата публикации: 09-08-2026 11:58:48

Auna (NYSE:AUNA – Get Free Report) and Marpai (NASDAQ:MRAI – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership. Insider and Institutional Ownership 49.7% of Marpai shares are […]

Основное содержимое страницы с новостью.

Posted by Mitch Edgeman on Aug 9th, 2026

Auna (NYSE:AUNAGet Free Report) and Marpai (NASDAQ:MRAIGet Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership.

Insider and Institutional Ownership

49.7% of Marpai shares are held by institutional investors. 46.1% of Marpai shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk and Volatility

Auna has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, Marpai has a beta of 4.74, meaning that its share price is 374% more volatile than the S&P 500.

Profitability

This table compares Auna and Marpai’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Auna 1.53% 16.25% 4.03%
Marpai -85.70% N/A -100.23%
Valuation and Earnings

This table compares Auna and Marpai”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Auna $4.52 billion 0.09 $27.39 million $0.26 20.44
Marpai $34.87 million 1.70 -$28.75 million ($0.87) -2.53

Auna has higher revenue and earnings than Marpai. Marpai is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings for Auna and Marpai, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Auna 1 2 1 1 2.40
Marpai 0 0 0 0 0.00

Auna presently has a consensus target price of $6.97, suggesting a potential upside of 31.08%. Given Auna’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Auna is more favorable than Marpai.

Summary

Auna beats Marpai on 11 of the 15 factors compared between the two stocks.

About Auna

(Get Free Report)

Auna logoAuna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

About Marpai

(Get Free Report)

Marpai logoMarpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.

You might be interested in:

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Moderna (NASDAQ:MRNA) and Compugen (NASDAQ:CGEN) Head-To-Head Comparison011.1310-08-2026
2Analyzing biote (NASDAQ:BTMD) and Numinus Wellness (OTCMKTS:LKYSF)010.7710-08-2026
3Contrasting Sunlands Technology Group (NYSE:STG) & Medirom Healthcare Technologies (NASDAQ:MRM)09.3610-08-2026
4Analyzing Trio-Tech International (NYSE:TRT) & Ambiq Micro (NYSE:AMBQ)015.3110-08-2026
5Head-To-Head Contrast: Aercap (NYSE:AER) vs. Fifth Era Acquisition Corp I (NASDAQ:FERA)010.4810-08-2026
6Financial Analysis: OptimizeRx (NASDAQ:OPRX) versus Reliq Health Technologies (OTCMKTS:RQHTF)08.8610-08-2026
7Cannabis Sativa (OTCMKTS:CBDS) vs. OneMedNet (NASDAQ:ONMD) Critical Contrast08.8410-08-2026
8Comparing OmniAb (NASDAQ:OABI) & Twist Bioscience (NASDAQ:TWST)010.7610-08-2026
9Reviewing OFA Group (NASDAQ:OFAL) and Science Applications International (NASDAQ:SAIC)08.2710-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 12.29. Источник: www.themarketsdaily.com.